IRIS
SACCO, RODOLFO, COSMA, DAMIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.878
EU - Europa 1.999
AS - Asia 1.650
SA - Sud America 247
Continente sconosciuto - Info sul continente non disponibili 103
AF - Africa 25
OC - Oceania 2
Totale 6.904
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.825
CN - Cina 575
SG - Singapore 534
IE - Irlanda 516
UA - Ucraina 315
SE - Svezia 311
RU - Federazione Russa 303
BR - Brasile 197
VN - Vietnam 163
IT - Italia 135
HK - Hong Kong 124
IN - India 106
DE - Germania 105
FR - Francia 87
GB - Regno Unito 85
FI - Finlandia 82
TR - Turchia 63
CA - Canada 27
AR - Argentina 17
BE - Belgio 17
MX - Messico 12
CO - Colombia 11
EU - Europa 11
BD - Bangladesh 10
TW - Taiwan 10
JP - Giappone 8
ZA - Sudafrica 8
IQ - Iraq 7
PL - Polonia 7
EC - Ecuador 6
ID - Indonesia 6
RO - Romania 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
ES - Italia 5
PH - Filippine 5
PK - Pakistan 5
AL - Albania 4
AT - Austria 4
MA - Marocco 4
SA - Arabia Saudita 4
DO - Repubblica Dominicana 3
KE - Kenya 3
KR - Corea 3
KZ - Kazakistan 3
PY - Paraguay 3
TN - Tunisia 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
IR - Iran 2
JM - Giamaica 2
NI - Nicaragua 2
NL - Olanda 2
OM - Oman 2
PA - Panama 2
RS - Serbia 2
SN - Senegal 2
AU - Australia 1
BG - Bulgaria 1
BW - Botswana 1
CH - Svizzera 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
KY - Cayman, isole 1
LB - Libano 1
LT - Lituania 1
MK - Macedonia 1
MY - Malesia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 6.812
Salva come PNG Salva come JPEG
Città #
Dublin 515
San Jose 445
Chandler 323
Singapore 269
Jacksonville 220
Nyköping 195
Ashburn 178
Beijing 148
Dearborn 148
Hong Kong 124
Nanjing 114
Wilmington 93
Dong Ket 75
Council Bluffs 70
Santa Clara 68
Ann Arbor 65
Columbus 60
New York 56
Princeton 55
San Mateo 54
Lauterbourg 52
Woodbridge 50
Moscow 49
Nanchang 38
Dallas 36
Helsinki 35
Boardman 31
Munich 31
Ho Chi Minh City 29
Philadelphia 28
Hanoi 24
Cedar Knolls 23
Leland 23
Los Angeles 23
Shenyang 23
Tianjin 20
Changsha 19
Stevenage 19
São Paulo 18
Brussels 17
Jiaxing 17
Hebei 16
Alexandria 14
Des Moines 13
Kunming 13
Hilden 12
Guangzhou 10
Milan 10
Banqiao 9
Bari 9
Belo Horizonte 9
Brasília 9
Hangzhou 9
Rio de Janeiro 9
Toronto 9
Chicago 8
Foggia 8
Nuremberg 8
Orem 8
Phoenix 8
Rome 7
Shanghai 7
Atlanta 6
Changchun 6
Chennai 6
Frankfurt am Main 6
Kocaeli 6
Las Vegas 6
London 6
Ningbo 6
North Bergen 6
The Dalles 6
Tokyo 6
Auburn Hills 5
Borås 5
Curitiba 5
Da Nang 5
Houston 5
Leawood 5
Porto Alegre 5
Seattle 5
Warsaw 5
Augusta 4
Brooklyn 4
Buffalo 4
Cluj 4
Fairfield 4
Hillsboro 4
Jinan 4
Johannesburg 4
Ninh Bình 4
Pune 4
San Francisco 4
Taizhou 4
Turku 4
Washington 4
Zhengzhou 4
Asunción 3
Baghdad 3
Campo Grande 3
Totale 4.265
Salva come PNG Salva come JPEG
Nome #
Chemioembolizzazione con particelle embolizzanti a rilascio farmacologico (DEB-TACE) vs tecnica convenzionale (TACE): risposta tumorale e sopravvivenza in pazienti con HCC 267
228 CONVENTIONAL TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (C-TACE) VERSUS DOXORUBICIN ELUTING BEAD (DEB)-TACE FOR HEPATOCELLULAR CARCINOMA: ASSESSMENT OF CLINICAL IMPACT-SHORT AND LONG-TERM PROSPECTIVE STUDY 236
392 HBeAg defective mutants in active/inactive anti-HBe positive HBV carriers: Possible role of pre-core initiation mutants 175
526 Liver stiffness measured by transient elastography. The influence of biochemical activity 169
504 HBV quasispecies selected during lamivudine treatment may contribute to adefovir dipivoxil resistance 164
The tightly regulated inducible expression of the core protein of hepatitis C virus modulates Fas- and TNF alpha-mediated apoptosis in human liver cells 164
[GLUTATHIONE IN THE TREATMENT OF CHRONIC FATTY LIVER DISEASES] 161
Cost effective prediction of sustained response to IFN Alfa-2B or PEG-IFN Alfa 2B plus Ribavirin computing infected cells dynamics by early ALT and HCV-RNA decline 140
Liver inflammation and acute respiratory distress syndrome in a patient receiving hepatitis B vaccine: a possible relationship? 138
Antiapoptotic regulation by hepatitis C virus core protein through up-regulation of inhibitor of caspase-activated DNase. 137
HBeAg defective mutants in active/inactive anti-HBe positive HBsAg carriers: possible role of pre-core initiation mutants 136
Transient elastography improves the management of CHB patients 136
Early prediction of sustained response in chronic hepatitis C patients treated with pegilated IFNs (A-2B or A-2A) plus ribavirin using a bio-mathematical model that describes the dynamics of infected cells 134
Complete response for advanced liver cancer during sorafenib therapy: case report. 134
Survival after transarterial chemoembolization in early-stage HCC patients excluded from liver transplantation: a prospective cohort study 132
EARLY AND COST EFFECTIVE PREDICTION OF TREATMENT OUTCOME WITH IFNA2B OR PEG-IFNA2B PLUS RIBAVIRIN COMPUTING INFECTED CELLS DYNAMICS BY ALT AND HCV-RNA DECLINE DURING THE FIRST MONTH 129
Entecavir for Hepatitis B Virus Flare Treatment in Patients with Crohn’s Disease 128
Clinical impact of selective transarterial chemoembolization on hepatocellular carcinoma: a cohort study 128
Hepatitis C virus serotypes in haemodialysis patients in South-East Italy. 127
Selective transcatheter arterial chemoembolization for hepatocellular carcinoma: Evaluation of clinical impact-short and long-term prospective study 125
Liver stiffness measured by transient elastography: The influence of biochemical activity 124
Hepatitis C virus serotypes and sources of infection in patients with HCV-related chronic liver disease from one geographical area in southeast Italy. 121
Emergence of hepatitis B virus quasispecies with lower susceptibility to nucleos(t)ide analogues during lamivudine treatment. 120
Transforming growth factor beta1 and soluble Fas serum levels in hepatocellular carcinoma. 120
Pulmonary or otolaryngologic extraesophageal manifestations in patients with gastroesophageal reflux disease 119
Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. 118
Distribution of hepatitis C virus serotypes and duration of infection in HCV infected subjects from a geographical area in Southeast Italy. 117
Feasibility and safety of granulocytapheresis in Crohn’s disease: A prospective color study 116
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis 115
Hepatitis C virus-RNA, immunoglobulin M anti-HCV and risk factors in haemodialysis patients. 115
The prevalence of hepatitis C virus types in patients of the same geographic area, according to the source of infection and liver disease. 114
MONITORING LIVER STIFFNESS: A NEW TOOL TO MEASURE LIVER FIBROSIS DURING THERAPY 114
sICAM-1, sCD95 and sCD95L levels in chronic liver diseases of different etiology. 113
Conventional vs Doxorubicin Eluting Bead Transcatheter Chemoembolization for Hepatocellular Carcinoma. 113
Efficacy of hemostatic powders in lower gastrointestinal bleeding: Clinical series and literature review 110
Monitoring liver elasticity: a new tool to measure liver fibrosis during therapy 109
A new model of HBV infection dynamics shows a multiphasic decay of viral load and a short half-life of circulating virus in anti-HBe positive patients treated with lamivudine 106
Adherence to AASLD guidelines in the real world of HCC in Italy preliminary results of a prospective study 104
Endotics system versus colonscopy for the detection of polyps a randomised trial 101
Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: A prospective cohort study. 100
Utilization of Hepatocellular Carcinoma Surveillance Programs in Patients With Cirrhosis: A Systematic Review and Meta-Analysis 97
TRANS-TACE: Prognostic Role of the Transient Hypertransaminasemia after Conventional Chemoembolization for Hepatocellular Carcinoma 96
Quantitative Determination of Hepatitis C Core Antigen in Therapy Monitoring for Chronic Hepatitis C. 95
Effectiveness of hemostatic powders in lower gastrointestinal bleeding: a systematic review and meta-analysis 95
Partial Response and Cardiovascular Recovery after Sorafenib Dose Reduction in a Multinodular HCC Patient. 91
Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma 88
Endotics system vs colonoscopy for the detection of polyps 87
Valutazione dell’impatto sulla funzionalità epatica della chemioembolizzazione in pazienti con epatocarcinoma tecnica convenzionale Versus particelle embolizzanti. 86
Bright Luminal Sign on High b-Value Diffusion-Weighted Magnetic Resonance Enterography Imaging as a New Biomarker to Predict Fibrotic Strictures in Crohn’s Disease Patients: A Retrospective Preliminary Study 85
Efficacy of combined transarterial radioembolization and sorafenib in the treatment of hepatocarcinoma: A meta-analysis 85
Towards a tailored systemic therapy for liver cancer 81
Sustained response to Interferon-ribavirin combination therapy in chronich hepatitis C predicted by a model of viral dynamics using both HCV-RNA and alanine amino transferase. 77
Cholangiocarcinoma in the Era of Immunotherapy 69
Stereotactic body radiotherapy vs radiofrequency ablation for the treatment of hepatocellular carcinoma: a meta-analysis 69
Prognostic Role of Post-Induction Fecal Calprotectin Levels in Patients with Inflammatory Bowel Disease Treated with Biological Therapies 68
Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review 66
Microwave Ablation Versus Radiofrequency Ablation for Treatment of Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled Trials 66
Target therapies plus somatostatin analogues in NETs: a network meta-analysis 60
Reply to Lissing et al. Comment on "Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947" 49
An Unusual Case of Herpes Zoster of the Hand Following a Physical Trauma: Case Report and Literature Review 38
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study 27
Totale 6.904
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.838
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.838
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022299 0 0 0 8 54 25 16 21 47 37 7 84
2022/20231.416 116 79 82 112 71 124 6 133 620 10 40 23
2023/2024183 42 14 4 4 16 62 2 5 2 14 1 17
2024/2025894 36 7 12 28 61 103 89 50 286 42 80 100
2025/20261.706 110 99 194 210 132 103 382 195 81 101 56 43
2026/2027464 38 147 119 160 0 0 0 0 0 0 0 0
Totale 6.904